337 | Humans |
277 | Lymphedema |
237 | Female |
196 | Human |
141 | Treatment |
128 | Middle Aged |
127 | Adult |
126 | Male |
106 | Aged |
84 | Lymphedema (etiology) |
70 | Complication |
57 | Lymphedema (therapy) |
53 | Malignant tumor |
52 | Case study |
51 | Upper limb |
45 | Lymphedema (diagnosis) |
45 | Child |
44 | Lower limb |
43 | Drainage |
42 | Aged, 80 and over |
41 | Mammary gland |
41 | Breast Neoplasms (surgery) |
40 | Lymphedema (complications) |
40 | Dermatology |
39 | Surgery |
38 | Kinesitherapy |
37 | Cardiovascular disease |
35 | Retrospective Studies |
35 | Prognosis |
35 | Diagnosis |
34 | Lymphedema (pathology) |
33 | Review |
33 | Adolescent |
32 | Treatment Outcome |
32 | Follow-Up Studies |
31 | Lymphedema (surgery) |
31 | Lymphedema (diagnostic imaging) |
31 | Arm |
31 | Animals |
30 | Technique |
30 | Lymphatic system |
30 | Diagnosis, Differential |
28 | Syndrome |
28 | Leg |
28 | Breast cancer |
25 | Lymph Node Excision (adverse effects) |
25 | Limb |
24 | Risk Factors |
23 | Breast Neoplasms (pathology) |
22 | Time Factors |
22 | Prospective Studies |
22 | Lymphedema (genetics) |
22 | Exploration |
22 | Breast Neoplasms (radiotherapy) |
21 | Radiotherapy |
21 | Infant |
20 | Young Adult |
20 | Physiotherapy |
19 | Skin |
19 | Lymph Node Excision (methods) |
19 | Compression |
19 | Breast Neoplasms (therapy) |
18 | Prevention |
18 | Erysipelas |
18 | Axilla |
17 | Lymphedema (physiopathology) |
17 | Lymphatic |
17 | Combined Modality Therapy |
16 | Infant, Newborn |
16 | Child, Preschool |
16 | Chemotherapy |
16 | Bandages |
15 | Scintigraphy |
15 | Physical Therapy Modalities |
15 | Indication |
15 | Chronic Disease |
14 | Treatment efficiency |
14 | Skin Neoplasms (pathology) |
14 | Risk factor |
14 | Neoplasm Staging |
14 | Mastectomy |
14 | Lymphoscintigraphy |
14 | Chronic |
13 | Restraint |
13 | Postoperative |
13 | Lymphatic Metastasis |
13 | Breast Neoplasms (complications) |
13 | Angiosarcoma |
12 | Severity of Illness Index |
12 | Radionuclide Imaging |
12 | Postoperative Complications (etiology) |
12 | Breast |
12 | Breast Neoplasms (drug therapy) |
12 | Arm (pathology) |
11 | Tomography, X-Ray Computed |
11 | Pathophysiology |
11 | Massage |
11 | Lymphatic vessel disease |
11 | Lymph Nodes (transplantation) |
11 | France |
11 | Elderly |
11 | Age Factors |
10 | Symptomatology |
10 | Survival Rate |
10 | Sarcoma |
10 | Primitive |
10 | Microsurgery (methods) |
10 | Medicine |
10 | Lymphedema (prevention & control) |
10 | Lymph node |
10 | Lymph Nodes (pathology) |
10 | Iatrogenic |
10 | Evolution |
10 | Elephantiasis, Filarial (parasitology) |
10 | Edema |
10 | Cancerology |
10 | Biopsy |
10 | Antineoplastic Combined Chemotherapy Protocols (therapeutic use) |
9 | Venous incompetence |
9 | Surgical Flaps |
9 | Skin (pathology) |
9 | Sensitivity and Specificity |
9 | Pressure |
9 | Lymphography |
9 | Lymphedema (epidemiology) |
9 | Lymphedema (congenital) |
9 | Lymphedema (chemically induced) |
9 | Lymphangiectasis |
9 | Lymph Node Excision |
9 | Lipoedema |
9 | Hand |
9 | Extremities |
9 | Etiology |
9 | Clinical management |
8 | Yellow nail syndrome |
8 | Scrotum |
8 | Rheumatology |
8 | Radiography |
8 | Quality of life |
8 | Quality of Life |
8 | Primary |
8 | Pregnancy |
8 | Phenotype |
8 | Penis |
8 | Mastectomy (adverse effects) |
8 | Manuals |
8 | Magnetic Resonance Imaging |
8 | Leg (pathology) |
8 | Elephantiasis, Filarial (diagnosis) |
8 | Classification |
7 | Surveys and Questionnaires |
7 | Secondary |
7 | Postoperative Complications (epidemiology) |
7 | Neoplasm Recurrence, Local |
7 | Lymphedema (drug therapy) |
7 | Lymphadenectomy |
7 | Lymph Nodes (diagnostic imaging) |
7 | France (epidemiology) |
7 | Eyelashes (abnormalities) |
7 | Elephantiasis, Filarial (epidemiology) |
7 | Elastic bandage |
7 | Cohort Studies |
7 | Bandage |
7 | Association |
6 | Survival Analysis |
6 | Substance Abuse, Intravenous (complications) |
6 | Sentinel Lymph Node Biopsy |
6 | Recurrence |
6 | Radiotherapy Dosage |
6 | Postoperative Complications |
6 | Pain (etiology) |
6 | Obesity (complications) |
6 | Neoplasms (complications) |
6 | Mutation |
6 | Mastectomy, Segmental |
6 | Lymphocele (etiology) |
6 | Lymphangiosarcoma |
6 | Lymph Nodes (surgery) |
6 | Incidence |
6 | Gynecology |
6 | Fatal Outcome |
6 | Erysipelas (etiology) |
6 | Epidemiology |
6 | Echography |
6 | Differential diagnostic |
6 | Computerized axial tomography |
6 | Carcinoma |
6 | Bibliographic review |
6 | Anastomosis, Surgical (methods) |
5 | Yellow Nail Syndrome (diagnosis) |
5 | Wuchereria bancrofti |
5 | Wuchereria bancrofti (isolation & purification) |
5 | Venous disease |
5 | Venotropic agent |
5 | Ultrasonography |
5 | Tumor |
5 | Surveillance |
5 | Stockings, Compression |
5 | Stewart Treves syndrome |
5 | Skin Neoplasms (surgery) |
5 | Skin Neoplasms (diagnosis) |
5 | Sentinel lymph node |
5 | Result |
5 | Reproducibility of Results |
5 | Relapse |
5 | Reeducation |
5 | Radiotherapy (adverse effects) |
5 | Public health |
5 | Postoperative Complications (diagnosis) |
5 | Pilot Projects |
5 | Pedigree |
5 | Pathogenesis |
5 | Nuclear magnetic resonance imaging |
5 | Melanoma (surgery) |
5 | Lymphedema (classification) |
5 | Lymphatic Vessels (surgery) |
5 | Lymphatic System (physiology) |
5 | Lymphangitis |
5 | Lymphangiosarcoma (pathology) |
5 | Lymphangiosarcoma (diagnosis) |
5 | Lymphangiectasis, Intestinal (diagnosis) |
5 | Lung |
5 | Infection |
5 | Hemangiosarcoma (pathology) |
5 | Head and neck |
5 | Exercise Therapy |
5 | Endometrial Neoplasms (surgery) |
5 | Elephantiasis, Filarial (transmission) |
5 | Elephantiasis, Filarial (complications) |
5 | Edema (etiology) |
5 | Double-Blind Method |
5 | Compressive bandage |
5 | Combined treatment |
5 | Circulatory system |
5 | Blood vessel |
5 | Anti-Bacterial Agents (therapeutic use) |
5 | Analysis of Variance |
4 | erysipelas |
4 | breast cancer |
4 | Yellow Nail Syndrome (complications) |
4 | Vein |
4 | Uterine Cervical Neoplasms (surgery) |
4 | Upper Extremity |
4 | Upper Extremity (surgery) |
4 | Tropical medicine |
4 | Toxicity |
4 | Telangiectasis (etiology) |
4 | Soft tissue |
4 | Skin disease |
4 | Skin Neoplasms (drug therapy) |
4 | Sirolimus (adverse effects) |
4 | Signal Transduction |
4 | Risk Assessment |
4 | Reference Values |
4 | Reconstructive Surgical Procedures (methods) |
4 | Radionuclide study |
4 | Obesity |
4 | Neoplasm Recurrence, Local (surgery) |
4 | Neoplasm Metastasis |
4 | Morbidity |
4 | Microsurgery |
4 | Mice |
4 | Mammaplasty (methods) |
4 | Lymphoma |
4 | Lymphocele (epidemiology) |
4 | Lymphedema (rehabilitation) |
4 | Lymphatic circulation |
4 | Lymphatic Metastasis (diagnosis) |
4 | Lymphangiectasis, Intestinal (complications) |
4 | Lower Extremity |
4 | Lipectomy |
4 | Leg (surgery) |
4 | Leg (diagnostic imaging) |
4 | Kinesitherapist |
4 | Instrumentation therapy |
4 | Immunohistochemistry |
4 | Hemangiosarcoma (diagnosis) |
4 | Hand (pathology) |
4 | Gerontology |
4 | Genetic disease |
4 | Forkhead Transcription Factors (genetics) |
4 | Foot |
4 | Flavonoid |
4 | Fibrosis |
4 | Feasibility Studies |
4 | Family study |
4 | Face |
4 | Erysipelas (prevention & control) |
4 | Erysipelas (epidemiology) |
4 | Equipment Design |
4 | Elephantiasis |
4 | Elephantiasis, Filarial (prevention & control) |
4 | Effusion |
4 | Drug addiction |
4 | Distichiasis |
4 | Disease-Free Survival |
4 | Disease Progression |
4 | DNA Mutational Analysis |
4 | Cross-Sectional Studies |
4 | Compression Bandages |
4 | Comparative study |
4 | Clinical investigation |
4 | Chemotherapy, Adjuvant |
4 | Cellulitis |
4 | Cardiology |
4 | Carcinoma, Ductal, Breast (radiotherapy) |
4 | Breast Neoplasms (psychology) |
4 | Breast Neoplasms (mortality) |
4 | Bacteriosis |
4 | Antineoplastic agent |
4 | Antibiotic |
4 | Anatomy |
4 | Anastomosis, Surgical |
4 | Abnormalities, Multiple (genetics) |
4 | Abdomen |
3 | Weight Loss |
3 | Volumetric analysis |
3 | Venules (surgery) |
3 | Vascular Endothelial Growth Factor Receptor-3 (genetics) |
3 | Varicose Veins (surgery) |
3 | Uterine Cervical Neoplasms (pathology) |
3 | Unilateral |
3 | Ultrasonography, Prenatal |
3 | Tumor Suppressor Proteins (genetics) |
3 | Transplantation, Autologous |
3 | Thrombosis |
3 | Surgical resection |
3 | Surgical Wound Dehiscence (etiology) |
3 | Surgical Flaps (blood supply) |
3 | Suction |
3 | Statistics, Nonparametric |
3 | Skin Ulcer (etiology) |
3 | Skin Neoplasms (diagnostic imaging) |
3 | Skin Diseases (pathology) |
3 | Skin Diseases (diagnosis) |
3 | Skin Care |
3 | Sex Factors |
3 | Sex Distribution |
3 | Retrospective |
3 | Reoperation |
3 | Remission Induction |
3 | Recommendation |
3 | Rats |
3 | Randomized Controlled Trials as Topic |
3 | Radiotherapy, Adjuvant (adverse effects) |
3 | Radiation Injuries (etiology) |
3 | Quantitative analysis |
3 | Program Evaluation |
3 | Postoperative Complications (therapy) |
3 | Postoperative Complications (surgery) |
3 | Pleura |
3 | Pediatrics |
3 | Patient Selection |
3 | Patient Education as Topic |
3 | Pain |
3 | Odds Ratio |
3 | Obstetrics |
3 | Nutritional status |
3 | Noonan Syndrome (complications) |
3 | Neoplasm Recurrence, Local (pathology) |
3 | Neoadjuvant Therapy |
3 | Necrosis |
3 | Neck |
3 | Nail(anatomy) |
3 | Nail Diseases (etiology) |
3 | Nail Diseases (complications) |
3 | Mutation, Missense |
3 | Multivariate Analysis |
3 | Multicenter study |
3 | Models, Biological |
3 | Microfilariae (isolation & purification) |
3 | Melanoma (pathology) |
3 | Mastectomy, Segmental (adverse effects) |
3 | Mastectomy (methods) |
3 | Mammary gland diseases |
3 | Lymphography (methods) |
3 | Lymphedema (psychology) |
3 | Lymphatic System (surgery) |
3 | Lymphatic System (pathology) |
3 | Lymphatic System (anatomy & histology) |
3 | Lymphatic Irradiation (adverse effects) |
3 | Lymphatic Diseases (complications) |
3 | Lymphangiosarcoma (drug therapy) |
3 | Lymphangioma (pathology) |
3 | Lymphangiogenesis (physiology) |
3 | Lymphangiogenesis (genetics) |
3 | Lymphangiectasis, Intestinal (pathology) |
3 | Lymphangiectasis, Intestinal (genetics) |
3 | Lymphangiectasis (pathology) |
3 | Lymph node metastasis |
3 | Lung Diseases (diagnosis) |
3 | Long term |
3 | Logistic Models |
3 | Length of Stay |
3 | Leg Length Inequality (etiology) |
3 | Leg (anatomy & histology) |
3 | Laparoscopy |
3 | Kidney Transplantation |
3 | Kaposi sarcoma |
3 | Irradiation |
3 | Intellectual Disability (genetics) |
3 | Insect Vectors (parasitology) |
3 | Inguinal |
3 | Inaugural sign |
3 | In Situ Hybridization, Fluorescence |
3 | Immunosuppressive Agents (adverse effects) |
3 | Image Processing, Computer-Assisted |
3 | Iatrogenic Disease |
3 | Hyposalivation |
3 | Hygiene |
3 | Hydrops Fetalis (genetics) |
3 | Hospitalization |
3 | Health Surveys |
3 | Head and Neck Neoplasms (pathology) |
3 | Gut |
3 | Groin |
3 | Genetic determinism |
3 | Genetic Predisposition to Disease |
3 | Fever |
3 | Extremities (pathology) |
3 | Exeresis |
3 | Evaluation |
3 | Endoscopy |
3 | Endometrial Neoplasms (pathology) |
3 | Endemic Diseases (prevention & control) |
3 | Elephantiasis, Filarial (history) |
3 | Drug Administration Schedule |
3 | Drainage (methods) |
3 | Disease |
3 | Diosmin |
3 | Dermatocellulitis |
3 | Debridement |
3 | Cyclophosphamide (administration & dosage) |
3 | Culex (parasitology) |
3 | Craniofacial Abnormalities (genetics) |
3 | Conservative surgery |
3 | Consanguinity |
3 | Confidence Intervals |
3 | Concomitant disease |
3 | Clinical form |
3 | Clinical Protocols |
3 | Chromosome Deletion |
3 | Chemoradiotherapy (adverse effects) |
3 | Cellulitis (etiology) |
3 | Cellulitis (complications) |
3 | Carcinoma, Lobular (surgery) |
3 | Carcinoma, Lobular (radiotherapy) |
3 | Carcinoma, Ductal, Breast (therapy) |
3 | Carcinoma, Ductal, Breast (surgery) |
3 | Carcinoma, Ductal, Breast (pathology) |
3 | Breast Neoplasms (diagnostic imaging) |
3 | Brachytherapy |
3 | Body Mass Index |
3 | Arm (surgery) |
3 | Antineoplastic Combined Chemotherapy Protocols (adverse effects) |
3 | Antineoplastic Agents (adverse effects) |
3 | Antineoplastic Agents (administration & dosage) |
3 | Anthelmintics (therapeutic use) |
3 | Ambulatory |
3 | Age of Onset |
3 | Africa |
3 | Adjuvant treatment |
3 | Acute Disease |
2 | yellow nail syndrome |
2 | microcirculation |
2 | Yellow Nail Syndrome (therapy) |
2 | Yellow Nail Syndrome (etiology) |
2 | Wuchereria bancrofti (growth & development) |
2 | Wound |
2 | World Health Organization |
2 | Woman |
2 | Vulvar Neoplasms (surgery) |
2 | Vulvar Neoplasms (pathology) |
2 | Volume |
2 | Venous Insufficiency (complications) |
2 | Vascular Surgical Procedures |
2 | Vascular Surgical Procedures (methods) |
2 | Vascular Endothelial Growth Factor C |
2 | Varix |
2 | Uterine Cervical Neoplasms (therapy) |
2 | Uterine Cervical Neoplasms (psychology) |
2 | Urine |
2 | Ultrasound |
2 | Turner syndrome |
2 | Treatment Failure |
2 | Travel |
2 | Trauma |
2 | Transcription Factors (genetics) |
2 | Tomography, Emission-Computed, Single-Photon |
2 | Telangiectasia |
2 | Technetium Tc 99m Sulfur Colloid |
2 | Taxoids (therapeutic use) |
2 | Survivors |
2 | Survey |
2 | Surgical Wound Infection (etiology) |
2 | Surgery, Plastic |
2 | Squamous cell carcinoma |
2 | Sonography |
2 | Somatostatin (analogs & derivatives) |
2 | Soft Tissue Neoplasms (surgery) |